Development of cell-based immunoassays to measure type I collagen in cultured fibroblasts

The International Journal of Biochemistry & Cell Biology
Brian JonesPitchumani Sivakumar

Abstract

Excessive deposition of type I collagen by activated fibroblasts is a hallmark of scarring and fibrotic pathologies. Quantitation of collagen I at the protein level is paramount to measure functionally relevant changes during pathological remodeling of the extracellular matrix. We describe two new cell-based assays to directly quantify the amount of collagen I incorporated into the extracellular matrix of primary human lung fibroblasts. Utilizing a monoclonal antibody specific to native human collagen I, we optimized conditions and parameters including incubation time, specificity and cell density to demonstrate dose-dependent induction of collagen I by transforming growth factor beta, as measured by in-cell enzyme linked immunosorbent assay. The results obtained by this assay were mimicked by an "In situ Quantitative Western Blot" on cultured cells using the same antibody. Results from these assays were comparable to those obtained with a commercial assay for collagen I N-propeptide, which is an index of collagen formation. These assays have been optimized for a 96-well format and provide a novel and useful approach for screening of anti-fibrotic agents in vitro. The assays described here also offer a significant improvement i...Continue Reading

References

Jan 1, 1990·The International Journal of Biochemistry·J A LastK M Reiser
Nov 1, 1990·Analytical Biochemistry·E E TredgetJ F Burke
Jan 1, 1989·Journal of Hepatology·G Biagini, G Ballardini
Aug 1, 1983·Seminars in Arthritis and Rheumatism·M E Nimni
Apr 3, 1998·Matrix Biology : Journal of the International Society for Matrix Biology·K I Kivirikko
Sep 28, 2000·Micron : the International Research and Review Journal for Microscopy·V OttaniA Ruggeri
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yutaka YataRichard A Rippe
Apr 26, 2003·Matrix Biology : Journal of the International Society for Matrix Biology·Johanna Myllyharju
Apr 1, 2004·Birth Defects Research. Part C, Embryo Today : Reviews·Karl Kadler
Aug 9, 2005·Pathologie-biologie·Sylvie Ricard-Blum, Florence Ruggiero
Dec 24, 2005·Journal of Thrombosis and Haemostasis : JTH·E M EgorinaB Østerud
Mar 10, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·James L GardnerMarc K Hellerstein
Jun 7, 2007·Journal of Cell Science·Karl E KadlerRaymond P Boot-Handford
Sep 19, 2007·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jyrki Heino
Jan 26, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Melinda C CushingKristi S Anseth

❮ Previous
Next ❯

Citations

Feb 23, 2018·American Journal of Physiology. Lung Cellular and Molecular Physiology·Delphine SicardDaniel J Tschumperlin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.